Literature DB >> 16361582

Multiple sclerosis related fatigue.

G Giovannoni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16361582      PMCID： PMC2117414          DOI： 10.1136/jnnp.2005.074948

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  14 in total

1.  Fatigue.

Authors:  Richard Barnett
Journal:  Lancet       Date:  2005 Jul 2-8       Impact factor: 79.321

2.  Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis.

Authors:  M Filippi; M A Rocca; B Colombo; A Falini; M Codella; G Scotti; G Comi
Journal:  Neuroimage       Date:  2002-03       Impact factor: 6.556

3.  Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study.

Authors:  K W Rammohan; J H Rosenberg; D J Lynn; A M Blumenfeld; C P Pollak; H N Nagaraja
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

4.  Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.

Authors:  B Stankoff; E Waubant; C Confavreux; G Edan; M Debouverie; L Rumbach; T Moreau; J Pelletier; C Lubetzki; M Clanet
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

Review 5.  Humoral links between sleep and the immune system: research issues.

Authors:  James M Krueger; Jeannie A Majde
Journal:  Ann N Y Acad Sci       Date:  2003-05       Impact factor: 5.691

6.  Association of fatigue and brain atrophy in multiple sclerosis.

Authors:  Ruth Ann Marrie; Elizabeth Fisher; Deborah M Miller; Jar-Chi Lee; Richard A Rudick
Journal:  J Neurol Sci       Date:  2004-12-21       Impact factor: 3.181

7.  Cytokine mRNA expression in patients with multiple sclerosis and fatigue.

Authors:  Peter Flachenecker; Irene Bihler; F Weber; M Gottschalk; Klaus V Toyka; Peter Rieckmann
Journal:  Mult Scler       Date:  2004-04       Impact factor: 6.312

Review 8.  Amantadine for fatigue in multiple sclerosis.

Authors:  C Taus; G Giuliani; E Pucci; R D'Amico; A Solari
Journal:  Cochrane Database Syst Rev       Date:  2003

9.  Fatigue is not associated with raised inflammatory markers in multiple sclerosis.

Authors:  G Giovannoni; A J Thompson; D H Miller; E J Thompson
Journal:  Neurology       Date:  2001-08-28       Impact factor: 9.910

10.  A controlled trial of natalizumab for relapsing multiple sclerosis.

Authors:  David H Miller; Omar A Khan; William A Sheremata; Lance D Blumhardt; George P A Rice; Michele A Libonati; Allison J Willmer-Hulme; Catherine M Dalton; Katherine A Miszkiel; Paul W O'Connor
Journal:  N Engl J Med       Date:  2003-01-02       Impact factor: 91.245
View more
  25 in total

1.  Assessing fatigue in multiple sclerosis: shedding light on the elephant in the dark.

Authors:  Michael J Decker
Journal:  Sleep       Date:  2010-08       Impact factor: 5.849

2.  Multiple sclerosis fatigue relief by bilateral somatosensory cortex neuromodulation.

Authors:  Franca Tecchio; Andrea Cancelli; Carlo Cottone; Giancarlo Zito; Patrizio Pasqualetti; Anna Ghazaryan; Paolo Maria Rossini; Maria Maddalena Filippi
Journal:  J Neurol       Date:  2014-05-23       Impact factor: 4.849

3.  Sustained-released fampridine in multiple sclerosis: effects on gait parameters, arm function, fatigue, and quality of life.

Authors:  Etienne Allart; Anne Benoit; Anne Blanchard-Dauphin; Vincent Tiffreau; André Thevenon; Hélène Zephir; Olivier Outteryck; Arnaud Lacour; Patrick Vermersch
Journal:  J Neurol       Date:  2015-06-05       Impact factor: 4.849

Review 4.  A mechanism for sickness sleep: lessons from invertebrates.

Authors:  Kristen C Davis; David M Raizen
Journal:  J Physiol       Date:  2017-02-22       Impact factor: 5.182

5.  Explaining fatigue in multiple sclerosis: cross-validation of a biopsychosocial model.

Authors:  Melloney L M Wijenberg; Sven Z Stapert; Sebastian Köhler; Yvonne Bol
Journal:  J Behav Med       Date:  2016-05-28

6.  Italian translation and validation of fatigue symptoms and impacts questionnaire in relapsing multiple sclerosis (FSIQ-RMS).

Authors:  Ilaria Ruotolo; Giovanni Sellitto; Antonio Ianniello; Nikolaos Petsas; Letizia Castelli; Giovanni Galeoto; Anna Berardi; Valeria Barletta; Antonella Conte; Carlo Pozzilli
Journal:  Neurol Sci       Date:  2022-04-22       Impact factor: 3.830

Review 7.  Impaired Neurovisceral Integration of Cardiovascular Modulation Contributes to Multiple Sclerosis Morbidities.

Authors:  Zohara Sternberg
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

8.  Comparison of the Psychometric Properties of Three Fatigue Scales in Persian-Speaking Patients with Multiple Sclerosis.

Authors:  Shabnam Behrangrad; Amin Kordi Yoosefinejad
Journal:  Int J MS Care       Date:  2020-02-14

Review 9.  Quality of life in multiple sclerosis.

Authors:  Józef A Opara; Krystyna Jaracz; Waldemar Brola
Journal:  J Med Life       Date:  2010 Oct-Dec

10.  Psychosocial factors involved in memory and cognitive failures in people with myalgic encephalomyelitis/chronic fatigue syndrome.

Authors:  Elizabeth A Attree; Megan A Arroll; Christine P Dancey; Charlene Griffith; Amolak S Bansal
Journal:  Psychol Res Behav Manag       Date:  2014-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.